Concepedia

Publication | Closed Access

Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study

18

Citations

9

References

2020

Year

Abstract

Tocilizumab and other IL-6 receptor monoclonal antibodies may evolve as a viable option in treating patients with moderate and severe COVID-19.

References

YearCitations

Page 1